JONATHAN LEI to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications JONATHAN LEI has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.175
-
Phase 2 study of neoadjuvant enzalutamide and paclitaxel for luminal androgen receptor-enriched TNBC: Trial results and insights into "ARness". Cell Rep Med. 2024 Jun 18; 5(6):101595.
Score: 0.143
-
Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer. Cancer Discov. 2022 11 02; 12(11):2586-2605.
Score: 0.032